Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FavId + Rituxan + GM-CSF in Follicular Lymphoma
NCT00041730Phase 2Unknown
- Sponsor
- Favrille, Inc.
- Start
- Jul 2002
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of FavId in follicular lymphoma (FL), sponsored by Favrille, Inc.. Status: unknown.
02
Drugs
FavId
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00041730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00041730.